Delivery Order SPE2DB22D2206-SPE2DB25FKD01
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Onfil 10 mg tablets (100-count) with a ceiling value of $12,795.99. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Onfil 10 mg tablets (100-count) under a firm fixed-price contract with a ceiling value of $7,471.73. This non-set-aside award is classified as a delivery order with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a specific pharmaceutical supply requirement within the...
- The Defense Logistics Agency awarded a $5,525.16 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Onfil 10 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with performance through July 29, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Onfil 10 mg tablets (100-count units) with a ceiling value of $4,414.14. This competitive, non-set-aside award reflects a firm fixed-price delivery order placed against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Onfil 10 mg tablets (100 count) with a ceiling value of $3,064.78. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Onfil 10 mg tablets (100 count) under a firm fixed price contract with a ceiling value of $9,377.00. This is a competitively awarded, non-set-aside delivery order to be completed by August 15, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child contract, this delivery order derives from AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $3,589.68 to AmerisourceBergen Drug Corp for Onfil 10 mg tablets (100 count) on July 10, 2025, with completion expected by July 11, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX, valued at $999,999,999.00 through December 2026). The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Onfil 10 mg tablets (100-count units) valued at $11,683.85 under a firm fixed-price contract type. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Onfil 10 mg tablets (100-count units) with a ceiling value of $3,109.20. This firm fixed-price, non-set-aside contract is classified as a delivery order with an ultimate completion date of September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for Onfil 10 mg tablets (100-count units) with a ceiling value of $11,281.66. This firm fixed-price delivery order, which represents a non-competitive set-aside contract, is scheduled for ultimate completion by August 1, 2025, with performance occurring at the awardee's Conshohocken facility. The contract was issued as a child order...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKD01Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Onfil 10 mg tablets (100-count packages) with a ceiling value of $9,422.61. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a significant federal contract portfolio primarily supporting the Defense Health Agency and other military healthcare systems. The company's extensive experience fulfilling federal medical procurement requirements through competitive delivery orders demonstrates its capability to supply a broad range of pharmaceutical products across multiple therapeutic domains. This particular order for Onfil tablets represents a routine execution under the larger DLA pharmaceutical prime vendor framework that enables flexible, efficient delivery of critical medical commodities to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 9/26/25 |